Sponsor:
Abramson Cancer Center at Penn Medicine
Code:
NCT06458439
Conditions
Lymphoma, Non-Hodgkin
Relapsed Diffuse Large B Cell Lymphoma
Refractory Diffuse Large B-cell Lymphoma
High-grade B-cell Lymphoma
Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Epcoritamab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-02. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2025-03-27.